Study Factors Associated with Early Complications of the Permanent Pacemaker Implantation: A Research Report in Vietnam.

IF 0.7 Q4 PHARMACOLOGY & PHARMACY
Journal of pharmacy & bioallied sciences Pub Date : 2024-07-01 Epub Date: 2024-07-31 DOI:10.4103/jpbs.jpbs_420_24
Giang Song Tran, Si Dung Chu, Minh Thi Tran
{"title":"Study Factors Associated with Early Complications of the Permanent Pacemaker Implantation: A Research Report in Vietnam.","authors":"Giang Song Tran, Si Dung Chu, Minh Thi Tran","doi":"10.4103/jpbs.jpbs_420_24","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>The permanent pacemaker implantation has a history of more than 60 years with improved mortality and quality of life but also recorded many complications.</p><p><strong>Objectives: </strong>The objective is to evaluate the rate of early complications at the National Heart Institute of Vietnam and the factors associated with the early complication of the permanent pacemaker implantation procedure.</p><p><strong>Methods: </strong>A cross-sectional descriptive is about 294 patients who received permanent pacemaker implantation at the National Heart Institute of Vietnam from 01/08/2020 to 30/30/2020.</p><p><strong>Results: </strong>The rate of complications is statistically higher in the diabetic group (OR = 2.5; 95% CI: 1.1-5.6), chronic kidney failure (OR = 2.7; 95% CI: 1.1-6.6), preheart surgery (OR = 3.8; 95% CI: 1.3-11.8), taking oral anticoagulants (OR = 4.3; 95% CI: 1.9-9.9), dual antiplatelets (OR = 2.95; 95% CI: 1.1-8.1), continuation to maintain anticoagulants, or dual antiplatelets (OR = 2.7; 95% CI: 1.2-6.4).</p><p><strong>Conclusion: </strong>Early onset of complications (onset of early complications) has been associated with some factors such as diabetes disease, chronic kidney failure, preheart surgery, oral anticoagulants, dual antiplatelets, continuation to maintain anticoagulation, and antiplatelets with statistical significance.</p>","PeriodicalId":94339,"journal":{"name":"Journal of pharmacy & bioallied sciences","volume":"16 Suppl 3","pages":"S2706-S2708"},"PeriodicalIF":0.7000,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11426802/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of pharmacy & bioallied sciences","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4103/jpbs.jpbs_420_24","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/7/31 0:00:00","PubModel":"Epub","JCR":"Q4","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: The permanent pacemaker implantation has a history of more than 60 years with improved mortality and quality of life but also recorded many complications.

Objectives: The objective is to evaluate the rate of early complications at the National Heart Institute of Vietnam and the factors associated with the early complication of the permanent pacemaker implantation procedure.

Methods: A cross-sectional descriptive is about 294 patients who received permanent pacemaker implantation at the National Heart Institute of Vietnam from 01/08/2020 to 30/30/2020.

Results: The rate of complications is statistically higher in the diabetic group (OR = 2.5; 95% CI: 1.1-5.6), chronic kidney failure (OR = 2.7; 95% CI: 1.1-6.6), preheart surgery (OR = 3.8; 95% CI: 1.3-11.8), taking oral anticoagulants (OR = 4.3; 95% CI: 1.9-9.9), dual antiplatelets (OR = 2.95; 95% CI: 1.1-8.1), continuation to maintain anticoagulants, or dual antiplatelets (OR = 2.7; 95% CI: 1.2-6.4).

Conclusion: Early onset of complications (onset of early complications) has been associated with some factors such as diabetes disease, chronic kidney failure, preheart surgery, oral anticoagulants, dual antiplatelets, continuation to maintain anticoagulation, and antiplatelets with statistical significance.

永久起搏器植入早期并发症的相关因素研究:越南研究报告
导言永久性心脏起搏器植入术已有 60 多年的历史,其死亡率和生活质量有所提高,但也记录了许多并发症:目的:评估越南国家心脏研究所的早期并发症发生率以及与永久性心脏起搏器植入术早期并发症相关的因素:方法:对2020年8月1日至2020年30月30日期间在越南国家心脏研究所接受永久性心脏起搏器植入手术的294名患者进行横断面描述:据统计,糖尿病组(OR = 2.5;95% CI:1.1-5.6)、慢性肾衰竭组(OR = 2.7;95% CI:1.1-6.6)、心脏手术前组(OR = 3.8;95% CI:1.3-11.8)、口服抗凝药组(OR = 3.8;95% CI:1.3-11.8)的并发症发生率较高。8)、口服抗凝药(OR = 4.3;95% CI:1.9-9.9)、双联抗血小板(OR = 2.95;95% CI:1.1-8.1)、继续维持抗凝药或双联抗血小板(OR = 2.7;95% CI:1.2-6.4):结论:并发症的早期发生(早期并发症的发生)与糖尿病、慢性肾衰竭、心脏手术前、口服抗凝药、双联抗血小板药物、继续维持抗凝药和抗血小板药物等因素有关,且具有统计学意义。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
1.40
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信